犬尿氨酸失衡作为精神疾病诊断和治疗中的潜在生物标志物 - Suppr

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders.

作者信息

Myint Aye-Mu, Halaris Angelos

机构信息

Department of Psychiatry, Loyola University School of Medicine and Loyola University Medical Center, Maywood, IL, United States.

出版信息

Front Psychiatry. 2022 Jun 28;13:913303. doi: 10.3389/fpsyt.2022.913303. eCollection 2022.

DOI:10.3389/fpsyt.2022.913303

PMID:35836656

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9275364/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f9/9275364/b4ca726bc068/fpsyt-13-913303-g0001.jpg

相似文献

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders.犬尿氨酸失衡作为精神疾病诊断和治疗中的潜在生物标志物

Front Psychiatry. 2022 Jun 28;13:913303. doi: 10.3389/fpsyt.2022.913303. eCollection 2022.

Esketamine for treatment resistant depression.艾氯胺酮用于治疗难治性抑郁症。

Expert Rev Neurother. 2019 Oct;19(10):899-911. doi: 10.1080/14737175.2019.1640604. Epub 2019 Jul 16.

Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance.治疗抵抗性抑郁症的实用建议：使用氯胺酮鼻喷雾剂治疗：基础科学、循证知识和专家指导。

World J Biol Psychiatry. 2021 Jul;22(6):468-482. doi: 10.1080/15622975.2020.1836399. Epub 2020 Nov 12.

The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report.在广泛的药物基因组学检测后，艾司氯胺酮用于治疗共病的难治性抑郁症和强迫症：一例报告

Ann Gen Psychiatry. 2021 Sep 16;20(1):43. doi: 10.1186/s12991-021-00365-z.

At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study.在基线时，接受 Esketamine 治疗的患者比其他治疗抵抗性抑郁症患者的疾病负担更高：基于人群的研究结果。

Depress Anxiety. 2021 May;38(5):521-527. doi: 10.1002/da.23138. Epub 2021 Jan 21.

Kynurenines: from the perspective of major psychiatric disorders.犬尿氨酸：从主要精神疾病的角度来看。

FEBS J. 2012 Apr;279(8):1375-85. doi: 10.1111/j.1742-4658.2012.08551.x. Epub 2012 Mar 27.

Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study.氯胺酮和艾司氯胺酮对治疗抵抗性抑郁症患者的神经认知影响：一项比较、随机、双盲研究。

Psychiatry Res. 2021 Sep;303:114058. doi: 10.1016/j.psychres.2021.114058. Epub 2021 Jun 7.

Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study.两种新型“标准治疗”方案——鼻内给予艾司氯胺酮与静脉给予氯胺酮——在自然临床实践中治疗难治性抑郁症的疗效和耐受性：一项初步观察性研究方案

JMIR Res Protoc. 2022 May 23;11(5):e34711. doi: 10.2196/34711.

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study.鼻腔内依他佐辛固定剂量作为口服抗抑郁药附加治疗对日本治疗抵抗性抑郁症患者的疗效和安全性：一项 2b 期随机临床研究。

BMC Psychiatry. 2021 Oct 25;21(1):526. doi: 10.1186/s12888-021-03538-y.

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review.氯胺酮和 Esketamine 对治疗抵抗性抑郁症的功能结局的疗效：系统评价。

J Affect Disord. 2021 Oct 1;293:285-294. doi: 10.1016/j.jad.2021.06.032. Epub 2021 Jun 24.

引用本文的文献

Decoding serotonin: the molecular symphony behind depression.解码血清素：抑郁症背后的分子交响曲。

Front Cell Neurosci. 2025 Apr 24;19:1572462. doi: 10.3389/fncel.2025.1572462. eCollection 2025.

Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology-From Bench to Bedside.用于脑部疾病和肿瘤学的基于色氨酸-犬尿氨酸途径的成像剂——从实验台到临床应用

Biomolecules. 2025 Jan 1;15(1):47. doi: 10.3390/biom15010047.

Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia.首发精神分裂症患者外周色氨酸-犬尿氨酸途径功能障碍

Sci Rep. 2025 Jan 18;15(1):2432. doi: 10.1038/s41598-025-86390-4.

Possible application of in stress management.（此处原文不完整，推测可能是某个东西在压力管理中的可能应用，但仅根据现有内容准确翻译为）在压力管理中的可能应用。

Microbiome Res Rep. 2024 Sep 10;3(4):48. doi: 10.20517/mrr.2023.81. eCollection 2024.

Metabolomic changes in children with autism.自闭症儿童的代谢组学变化。

World J Clin Pediatr. 2024 Jun 9;13(2):92737. doi: 10.5409/wjcp.v13.i2.92737.

The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain.C-3 侧链修饰对犬尿氨酸的影响：运动域中其类似物的行为分析。

Int J Mol Sci. 2024 Mar 16;25(6):3394. doi: 10.3390/ijms25063394.

Monomeric C-reactive protein as a biomarker for major depressive disorder.单体C反应蛋白作为重度抑郁症的生物标志物。

Front Psychiatry. 2024 Jan 5;14:1325220. doi: 10.3389/fpsyt.2023.1325220. eCollection 2023.

Psychiatric Comorbidities of Inflammatory Bowel Disease: It Is a Matter of Microglia's Gut Feeling.炎症性肠病的精神共病：这是一个关于小胶质细胞的直觉的问题。

Cells. 2024 Jan 17;13(2):177. doi: 10.3390/cells13020177.

Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD.脑犬尿氨酸途径代谢物水平可能反映肌萎缩侧索硬化症、额颞叶痴呆和早发性阿尔茨海默病的神经炎症程度。

Pharmaceuticals (Basel). 2023 Apr 19;16(4):615. doi: 10.3390/ph16040615.

本文引用的文献

In Vivo C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.用于评估健康与疾病状态下脑生物化学的活体碳磁共振波谱分析

Neurochem Res. 2022 May;47(5):1183-1201. doi: 10.1007/s11064-022-03538-8. Epub 2022 Jan 28.

Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology.精神分裂症患者死后前额叶皮层和小脑的犬尿氨酸途径：与单胺类物质和症状的关系。

J Neuroinflammation. 2021 Sep 12;18(1):198. doi: 10.1186/s12974-021-02260-6.

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.艾氯胺酮用于治疗抵抗性抑郁症——首个获美国食品药品监督管理局批准的新型抗抑郁药。

N Engl J Med. 2019 Jul 4;381(1):1-4. doi: 10.1056/NEJMp1903305. Epub 2019 May 22.

Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions.应激与抑郁中的皮质GABA能功能障碍：治疗干预的新见解

Front Cell Neurosci. 2019 Mar 12;13:87. doi: 10.3389/fncel.2019.00087. eCollection 2019.

Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease.色氨酸代谢产物过山车：在阿尔茨海默病中驶向神经保护的方向。

Expert Opin Ther Targets. 2018 Oct;22(10):849-867. doi: 10.1080/14728222.2018.1524877. Epub 2018 Sep 25.

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.鼻腔内使用艾司氯胺酮治疗有自杀风险的抑郁症和自杀意念患者快速减轻症状的疗效和安全性：一项双盲、随机、安慰剂对照研究的结果。

Am J Psychiatry. 2018 Jul 1;175(7):620-630. doi: 10.1176/appi.ajp.2018.17060720. Epub 2018 Apr 16.

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.鼻腔内依他佐辛辅助口服抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机临床试验。

JAMA Psychiatry. 2018 Feb 1;75(2):139-148. doi: 10.1001/jamapsychiatry.2017.3739.

Network abnormalities and interneuron dysfunction in Alzheimer disease.阿尔茨海默病中的网络异常与中间神经元功能障碍。

Nat Rev Neurosci. 2016 Dec;17(12):777-792. doi: 10.1038/nrn.2016.141. Epub 2016 Nov 10.

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.静脉用依他佐辛治疗成人治疗抵抗性抑郁症：一项双盲、双随机、安慰剂对照研究。

Biol Psychiatry. 2016 Sep 15;80(6):424-431. doi: 10.1016/j.biopsych.2015.10.018. Epub 2015 Nov 3.

Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression.产后期色氨酸代谢途径的改变与产后急性精神病和抑郁症。

J Affect Disord. 2016 Jan 1;189:298-305. doi: 10.1016/j.jad.2015.09.064. Epub 2015 Oct 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献